 |
|
Exacerbation Prevention and Management of Bronchiectasis
Joon Young Choi
Tuberc Respir Dis. 2023;86(3):183-195. Published online 2023 May 10 DOI: https://doi.org/10.4046/trd.2023.0010
|
|
Citations to this article as recorded by
 Disease Severity and Activity in Bronchiectasis: A Paradigm Shift in Bronchiectasis Management
Yunjoo Im, James D. Chalmers, Hayoung Choi
Tuberculosis and Respiratory Diseases.2025; 88(1): 109. CrossRef Long term management of people with post-tuberculosis lung disease
Wan Seo, Hyung Woo Kim, Ju Sang Kim, Jinsoo Min
The Korean Journal of Internal Medicine.2024; 39(1): 7. CrossRef Secondary Immunodeficiency and Non-cystic Fibrosis Bronchiectasis
Sungmin Zo, Ji-Yong Moon, Kyung Hoon Min, Hyun Lee
Tuberculosis and Respiratory Diseases.2024; 87(4): 440. CrossRef Effectiveness and safety of Qianjinweijing decoction in the treatment of bronchiectasis: A systematic review and meta-analysis
Limin Zhang, Jin Su, Xiaozheng Wu, Wen Li, Yunzhi Chen
European Journal of Integrative Medicine.2024; 72: 102418. CrossRef Bronchiectasis-COPD Overlap Syndrome: A Comprehensive Review of its Pathophysiology and Potential Cardiovascular Implications
Mohammad Ajaz Alam, Padmavathi Mangapuram, Fremita Chelsea Fredrick, Bhupinder Singh, Amishi Singla, Avi Kumar, Rohit Jain
Therapeutic Advances in Pulmonary and Critical Care Medicine.2024;[Epub] CrossRef Factors influencing poor response to type 2 targeted therapies in severe asthma: a retrospective cohort study
Mona Al-Ahmad, Asmaa Ali, Ahmed Maher
BMC Pulmonary Medicine.2023;[Epub] CrossRef
|